Since its start in 2007 the Schistosomiasis Elimination Program has hit major milestones. Over more than 15 years, Merck KGaA, Darmstadt, Germany has donated 2 billion tablets, enabling the treatment of 800 million patients, primarily school-aged children, in 47 countries all over sub-Saharan Africa.
We will also celebrate the critical milestone achieved for a new pediatric treatment option for preschool-aged children, which received the scientific positive opinion by the European Medicines Agency in December 2023. Read the press release here.
We will welcome a panel of distinguished guests, key global health experts, to give us first-hand insights into the critical efforts to achieve the ambitious elimination goal: Juerg Utzinger, Director Swiss Tropical and Public Health Institute (Swiss TPH), Pamela Mbabazi, Medical Epidemiologist at WHO, Michael Makanga, Executive Director of the Global Health EDCTP3 Joint Undertaking, and Sam Mayer, Vice President, Public Affairs at the END Fund.
We will display our Photo Exhibition “Leaving no one behind” during a period of two weeks, January 29 to February 9, 2024, in the Innovation Center of our Headquarter. It showcases the experience of young boy Manyazewal in Ethiopia, who caught schistosomiasis and could recover thanks to concerted international efforts.